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Is MEFV Gene Arg202Gln (605 G>A) A Disease-Causing
Mutation?
Aim: Familial Mediterranean fever (FMF) is an autosomal recessive disease. Arg202Gln was reported as a
frequent polymorphism, and G allele of the mutation was in linkage disequilibrium with M694V. Thus, the aim
of this study was to determine the distribution of the R202Q (605G>A) mutation in exon 2 of the MEFV gene
in Turkish FMF patients and controls.
Materials and Methods: The study included 160 FMF and 41 FMF/amyloid patients and 121 controls.
Sequencing of exon 10 and exon 5 and PCR/RFLP analysis of E148Q and R202Q mutations of exon 2 of the
MEFV gene were performed for all patients according to previously described techniques.
Results: We found that 5 out of 76 M694V homozygote FMF patients carry a different haplotype from the
one expected. Eleven of the patients had homozygous GG allele indicating the second haplotype. None of the
121 controls was homozygous for R202Q (605G>A), but 8 controls were heterozygous for M694V mutation
and 5 (4.1%) of them were in linkage disequilibrium with R202Q.
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Conclusions: It seems that R202Q has no effect when it is in heterozygous state; however, when combined
with another disease-causing mutation, the clinical spectrum appears. Thus, R202Q might be a disease-causing
mutation at least in some of the FMF patients.
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MEFV Arg202Gln (605 G>A) Taﬂ›ma Hastal›k Oluﬂturan Bir Mutasyon mu?
Amaç: Ailevi Akdeniz Ateﬂi (AAA) otozomal resesif kal›t›lan bir hastal›kt›r. Arg202Gln s›k görülen bir
polimorfizm olmakla birlikte G allelinin M694V ile birlikte kal›t›ld›¤› bildirilmiﬂtir. Bundan dolay› bu çal›ﬂman›n
amac›, MEFV geni 2. ekzonda yer alan R202Q (605 G>A) mutasyonunun Türk FMF hastalar›nda ve
kontrollerdeki da¤›l›m›n› göstermektir.
Yöntem ve Gereç: Çal›ﬂma, 160 FMF, 41 FMF/amiloid hastalar›n› ve 121 kontrolü kapsamaktad›r. 10 ve 5.
ekzonlar dizi analizi yöntemi ile, 2. ekzon E148Q ve R202Q mutasyonlar› için PCR/RFLP yöntemi ile daha önce
tan›mlanan tekniklere göre tüm bireyler taranm›ﬂt›r.
Bulgular: M694V homozigot olan 76 FMF hastas›n›n 5’i beklenenden farkl› bir haplotip taﬂ›maktad›r. 11
hastada homozigot GG alleli bulunmakta ve ikinci bir haplotipe iﬂaret etmektedir. 121 kontrolde homozigot
R202Q (605 G>A) bulunmamakta fakat 8 kontrolden 5’i (% 4,1) M694V mutasyonu için heterozigot ve
R202Q ile birleﬂik heterozigottur.
Sonuç: R202Q heterozigotlu¤u durumunda hastal›k yap›c› etkisi görülmemektedir. Fakat hastal›kla iliﬂkili
baﬂka bir mutasyonla birlikteli¤inde klini¤e etkisi görülmektedir. Bundan dolay› R202Q, en az›ndan baz› FMF
hastalar›nda, hastal›¤a neden olan bir mutasyon olabilir.
Anahtar Sözcükler: Ailevi Akdeniz Ateﬂi (AAA), Amiloid, MEFV geni, R202Q
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Familial Mediterranean fever (FMF, OMIM 249100) is characterized by recurrent
acute attacks of fever accompanied by abdominal pain, arthritis and pleurisy. The most
severe complication is the development of systemic amyloidosis, ultimately leading to
renal failure, but it can be prevented by the daily and life-long administration of
colchicine therapy (1-2). FMF primarily affects populations surrounding the
Mediterranean basin: Sephardic Jews, Armenians, Turks, Arabs, Greeks, Druze and
Ashkenazi Jews. Several mutations in the gene responsible for FMF have been reported
(3). Most of the previous reports are confined to exon 2 and exon 10 of the MEFV gene,
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as most of the mutations are clustered in these two exons
(1,4).
More
than
150
gene
alterations
(polymorphisms/mutations) located in the MEFV gene
have been identified (5).
During our MEFV gene mutation screening among
Turkish FMF patients for molecular diagnosis, we
detected R202Q (605 G>A) at exon 2 of the MEFV gene
in some of our patients. R202Q was reported as a
frequent polymorphism, and G allele of the mutation was
in linkage disequilibrium with M694V (5). During our
study, in some of our patients, we found that G allele was
not linked to M694V.
We thus aimed to study the distribution of the R202Q
(605 G>A) mutation in Turkish FMF patients and
controls.
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Results
Distribution of R202Q mutation among Turkish FMF
patients is given in Table 1, and Table 2 shows the
distribution of R202Q mutation among FMF patients
with amyloidosis. We found that 5 of 76 M694V
homozygote FMF patients without amyloidosis carry a
different haplotype from the one expected. These
patients carry G allele instead of A allele at R202Q. In
screening of the patient group with only one mutation
detected, 15 of these patients had homozygous AA allele.
Eleven of them had homozygous GG allele indicating the
second haplotype. Three heterozygous patients with
Table 1. Distribution of exon 2 R202Q mutation among Turkish FMF
patients.
R202Q

Materials and Methods
Patients
All patients were of Turkish origin, and diagnosis of
FMF was based upon the published criteria (6). The
patient group included 201 unrelated Turkish FMF
patients, of whom 76 were homozygous M694V without
amyloidosis and 84 were heterozygous for one MEFV
mutation (M694V [n=58]; E148Q [n=14]; V726A [n=6];
M680I [n=6]. Forty-one biopsy-proven FMF-amyloidosis
patients were also included. A written consent was
obtained from the parents of the children.
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GA

AA

M694V/M694V (n=76)

1

4

71

M694V/- (n=58)

11

32

15

Control (n=107)

71

36

-

E148Q/- (n=14)

11

3

-

V726A/- (n=6)

6

-

-

M680I/- (n=6)

6

-

-

Table 2. Distribution of exon 2 R202Q mutation among FMF
amyloidosis patients.
Exon 2 R202Q

Methods
Mutation analysis of exon 10 and exon 5 of the MEFV
gene was performed for all patients according to
previously described sequencing technique by using
automatic DNA sequencer (Beckman Coulter, USA).
E148Q mutation of exon 2 was analyzed with previously
described polymerase chain reaction (PCR)/restriction
endonuclease analysis (7,8). R202Q mutation of exon 2
was
analyzed
using
primers
F:5’ATCTTGGGCCCTAAACGTGG-3’ and R:5’-TCCTTCAGG
TCCGCAGATGC-3’ with an annealing temperature of 58o
C. 658 bp PCR product was restricted with Pvu II, which
recognizes the mutation. One-hundred twenty-one
individuals without any symptoms of FMF were also
included in the study as controls.

GG

GG

GA

AA

FMF+Amyloid (n=41)

14 (34.1%)

13 (31.7%)

14 (34.1%)

No mutation detected

7

2

2

M694V/-

1

3

4

M694V/M694V

1

-

8

M680I/M694V

-

3

-

M680I/-

1

1

-

(G/A) M680I/M694V

-

1

-

M694I/-

1

-

-

M694V/K695R

-

1

-

M694V/V726A

-

1

-

M694V/E148Q

-

1

-

M680I/M680I

1

-

-

M680I/V726A

1

-

-

V726A/-

1

-

-
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E148Q had heterozygous R202Q. Analysis of the
amyloidosis patients revealed two patients with
homozygous R202Q (AA allele) mutation. One patient
with homozygous M694V mutation had homozygous GG
allele. Four heterozygous patients with M694V had
homozygous R202Q. One patient was in compound state
for M680I and R202Q.
When we screened 121 individuals without any
symptoms of FMF, none was homozygous for R202Q
(605 G>A) but 41 (33.8%) were heterozygous for this
mutation. It was found that 8 controls (6.6%) had MEFV
mutations at exon 10 in heterozygous state. Seven
controls (5.8%) were heterozygous for M694V
mutation, consistent with the study in which M694V
mutation frequency was found as 3% (9). Five controls
(4.1%) were compound heterozygous with R202Q. A
control with M680I heterozygosity (0.8%) was also
determined.

Discussion
Debate still continues
relationship in FMF since the
(10,11). The main debate
between the mutation type
V726A and E148Q were
(1,12,13).

on phenotype-genotype
cloning of the MEFV gene
centers on the relation
and amyloidosis. M694V,
subjects of the debates

Recently, during routine mutation analysis of our FMF
patients, we observed that R202Q mutation exists at
exon 2 of the MEFV gene, which was reported as a
prevalent polymorphism with linkage disequilibrium with
M694V mutation (5). However, when we analyzed our
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patient groups, we found that there is one more
haplotype, which was not in linkage disequilibrium with
M694V, indicating that this might be a disease-causing
mutation at least in some FMF patients. As we found
homozygous R202Q in two cases with amyloidosis, this
may also confirm our hypothesis. Furthermore, when we
analyzed this mutation in the control group, the expected
value for R202Q homozygosity was estimated as 3%, but
interestingly, R202Q in homozygote state was not found
in our control group.
Recently, Giaglis et al. (14) reported MEFV mutation
distribution in Greek FMF patients. They also stated that
R202Q is common in the Greek population. In conclusion,
they stated that R202Q is a disease-causing mutation;
however, they did not mention the previously reported
linkage disequilibrium information concerning R202Q.
One important point should be taken into account.
R202Q mutation was also common in our control
population. It seems that it has no effect when it is in
heterozygous state. However, when combined with
another disease-causing mutation, the clinical spectrum
appears. Further, it is also important from the diagnostic
point of view. If it is a disease- causing mutation, it will
be included in the routine mutation screening. Evaluation
of this mutation in different ethnic patient groups should
be performed as soon as possible.
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